Summary
The effect of metergoline on insulin secretion has been evaluated in normal subjects and in patients with chemical diabetes. The repeated administration of metergoline, 2 mg at four-hour intervals to give a total of 24 mg, has enhanced insulin secretion in response to i. v. glucose in normal subjects but not in chemical diabetics. No changes in blood glucose pattern were observed. Under similar conditions, metergoline administration caused a slight but significant decrease in arginine-induced insulin release, both in normal subjects and in chemical diabetics. These results support the concept of a serotoninergic control of insulin secretion and suggest that serotonin exerts different effects on insulin release according to the different stimuli.
Article PDF
Avoid common mistakes on your manuscript.
References
Cegrell, L.: The occurrence of biogenic amines in the mammalian endocrine pancreas. Acta physiol. scand. Suppl. 314, 1–60 (1968)
Federspil, G., Casara, D., Pedrazzoli, S., Sicolo, N., Scandellari, C.: In vivo studies on 5-hydroxytryptamine and ininsulin secretion in dogs and in man. Diabetologia 10, 13–17 (1974)
Telib, M., Raptis, S., Schroeder, K. E., Pfeiffer, E. F.: Serotinin and insulin release in vitro. Diabetologia 4, 253–256 (1968)
Lebovitz, H. E., Feldman, J. M.: Pancreatic biogenic amines and insulin secretion in health and disease. Fed. Proc. 32, 1797–1802 (1973)
Quickel, K. E. jr., Feldman, J. M., Lebovitz, H. E.: Inhibition of insulin secretion by serotonin and dopamine: species variation. Endocrinology 89, 1295–1302 (1971)
Trisotto, A., Frezzato, S., Federspil, G., Scandellari, C.: Tolleranza ai carboidrati e risposta insulinica in un caso di carcinoide. Min. med. 61, 680–683 (1970)
Feldman, J. M., Marecek, R. L., Quickel, K. E. jr., Lebovitz H. E.: Hyperserotoninemia: a cause of secondary diabetes mellitus. Clin. Res. 20, 55 (1972)
Quickel, K. E. jr., Feldman, J. M., Lebovitz, H. E.: Enhancement of insulin secretion in adult-onset diabetes mellitus by methysergide maleate: evidence for an endogenous biogenic monoamine mechanism as a factor in the impaired insulin release in diabetes mellitus. J. clin. Endocr. 33, 877–881 (1971)
Drash, A., Elliott, J., Langs, H., Lavenstein, A. F., Cooke, R. E.: The effect of cyproheptadine on carbohydrate metabolism. Clin. Pharmacol. Ther. 7, 340–346 (1966)
Beretta, C., Ferrini, R., Classer, A. H.: 1-methyl-8-β-carbobenzyloxy-aminoethyl-10-α-ergoline, a potent and long lasting 5-hydroxytryptamine antagonist. Nature (Lond.) 207, 421–422 (1965)
Beretta, C., Glässer, A. H., Nobili, M. B., Silvestri, R.: Antagonism of 5-hydroxytryptamine-induced bronchospasm in guinea-pigs by 8-β-carbobenzilaminomethyl-1-methyl-10-α-ergoline. J. Pharm. Pharmacol. 17, 423–428 (1965)
Huggett, A. St. G., Nixon, D. A.: Use of glucose oxidase, peroxidase and o-dianisidine in determination of blood and urinary glucose. Lancet 1957 II, 368–370
Hales, C. N., Randle, P. J.: Immunoassay of insulin with insulin antibody precipitate. Biochem. J. 88, 137–146 (1963)
Marble, A.: Laboratory procedures useful in diagnosis and treatment. In: Joslin's Diabetes mellitus. Philadelphia: Lea & Febiger 1971
De Caro, G.: Azione antagonista di un nuovo derivato dell' acido lisergico sulla antidiuresi da 5-idrossitriptamina nel ratto. Farmaco Ed. sci. 20, 781–785 (1965)
Fregnan, G. B.: The inhibitory effect of metergoline (an anti-5-hydroxytryptamine agent) on rabbit platelet aggregation. Pharmacology 7, 115–125 (1972)
Fajans, S. S., Christensen, H. N., Floyd, J. C., Pek, S.: Stimulation of insulin and glucagon release in the dog by a nonmetabolizable arginine analog. Endocrinology 94, 230–233 (1974)
Efendic, A., Cerasi, E., Luft, R.: Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic and diabetic subjects. Diabetes 23, 161–171 (1974)
Blackard, W. G., Andrews, S. S.: Dual action of phentolamine on insulin release from isolated rat islets. Diabetes 23, Suppl. 1, 365 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pontiroli, A.E., Viberti, G.C., Tognetti, A. et al. Effect of metergoline, a powerful and long-acting antiserotoninergic agent, on insulin secretion in normal subjects and in patients with chemical diabetes. Diabetologia 11, 165–167 (1975). https://doi.org/10.1007/BF00429842
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00429842